A 24-month metformin treatment study of children with obesity: Changes in circulating GDF-15 and associations with changes in body weight and visceral fat

Carreras-Badosa, G; Gomez-Vilarrubla, A; Mas-Pares, B; Martinez-Calcerrada, JM; Xargay-Torrent, S; Prats-Puig, A; Puerto-Carranza, E; Diaz-Roldan, F; de Zegher, F; Ibanez, L; Bassols, J; Lopez-Bermejo, A

Bassols, J (通讯作者),Girona Inst Biomed Res, C Dr Castany S-N, Salt 17190, Spain.;Lopez-Bermejo, A (通讯作者),Girona Inst Biomed Res, Pediat Endocrinol Grp, Av Franca S-N, Girona 17007, Spain.

PEDIATRIC OBESITY, 2022; 17 (2):

Abstract

Background Metformin treatment for 24 months in children with obesity lowers body mass index (BMI), reduces liver fat, and normalizes endocrine-metabo......

Full Text Link